Saved in:
Bibliographic Details
Main Authors: Rohan Sharma, Yu Ozawa, Marcio C. Moschovas, Shady Saikali, Marco Sandri, Travis Rogers, Vipul R. Patel
Format: Artículo Open Access
Published: Wiley 2025
Subjects:
Online Access:https://onlinelibrary.wiley.com/doi/10.1002/pros.70021
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1867016637194960896
author Rohan Sharma
Yu Ozawa
Marcio C. Moschovas
Shady Saikali
Marco Sandri
Travis Rogers
Vipul R. Patel
author_facet Rohan Sharma
Yu Ozawa
Marcio C. Moschovas
Shady Saikali
Marco Sandri
Travis Rogers
Vipul R. Patel
Rohan Sharma
Yu Ozawa
Marcio C. Moschovas
Shady Saikali
Marco Sandri
Travis Rogers
Vipul R. Patel
collection Wiley Open Access
contents Impact of Intraoperative Enlarged Median Lobe on Functional Recovery Following Robot‐Assisted Radical Prostatectomy: A Retrospective Cohort Analysis Rohan Sharma Yu Ozawa Marcio C. Moschovas Shady Saikali Marco Sandri Travis Rogers Vipul R. Patel The Prostate ABSTRACTBackgroundThe impact of intraoperative enlarged median lobe (EML) on outcomes following robot‐assisted radical prostatectomy (RARP) remains underexplored. We aimed to evaluate the functional and oncological outcomes in patients with and without EML undergoing RARP.MethodsWe retrospectively reviewed 9710 patients who underwent RARP between 2012 and 2021. Patients were stratified into two groups based on intraoperative identification of EML: Group A (no EML, n = 7985) and Group B (EML, n = 1725). Perioperative, pathological, functional, and oncological outcomes were compared. Kaplan‐Meier survival curves and log‐rank tests were used to assess biochemical recurrence (BCR) and functional recovery.ResultsMedian follow‐up was 72 months. Patients in Group B were older (65 vs. 63 years, p < 0.001), had higher PSA (6.20 vs. 5.76 ng/mL, p < 0.001), and lower PSA density (0.09 vs. 0.12 ng/mL/cc, p < 0.001). Group B had more low‐risk disease (29.8% vs. 24.1%, p < 0.001) and ISUP Grade Group 1 on biopsy (36.1% vs. 26.7%, p < 0.001). Operative time was longer in Group B (119 vs. 110 min, p < 0.001). Continence outcomes were comparable (p = 0.3). Among patients aged < 55 years with baseline SHIM > 21, potency recovery was high regardless of EML or nerve‐sparing status. Group B demonstrated a significantly lower 10‐year cumulative BCR rate (p = 0.042).ConclusionsRARP in patients with EML is associated with favorable oncological outcomes and equivalent continence recovery. Potency recovery is primarily influenced by age and baseline sexual function, rather than EML presence or nerve‐sparing.Trial Registration: This study is part of the prostate cancer registry (No. 237998). 10.1002/pros.70021 http://onlinelibrary.wiley.com/termsAndConditions#vor
doi_str_mv 10.1002/pros.70021
format Artículo Open Access
id wiley_oa_10_1002_pros_70021
institution Wiley Open Access
license_str_mv http://onlinelibrary.wiley.com/termsAndConditions#vor
publishDate 2025
publisher Wiley
record_format wiley_oa
spellingShingle Impact of Intraoperative Enlarged Median Lobe on Functional Recovery Following Robot‐Assisted Radical Prostatectomy: A Retrospective Cohort Analysis
Rohan Sharma
Yu Ozawa
Marcio C. Moschovas
Shady Saikali
Marco Sandri
Travis Rogers
Vipul R. Patel
The Prostate
Impact of Intraoperative Enlarged Median Lobe on Functional Recovery Following Robot‐Assisted Radical Prostatectomy: A Retrospective Cohort Analysis Rohan Sharma Yu Ozawa Marcio C. Moschovas Shady Saikali Marco Sandri Travis Rogers Vipul R. Patel The Prostate ABSTRACTBackgroundThe impact of intraoperative enlarged median lobe (EML) on outcomes following robot‐assisted radical prostatectomy (RARP) remains underexplored. We aimed to evaluate the functional and oncological outcomes in patients with and without EML undergoing RARP.MethodsWe retrospectively reviewed 9710 patients who underwent RARP between 2012 and 2021. Patients were stratified into two groups based on intraoperative identification of EML: Group A (no EML, n = 7985) and Group B (EML, n = 1725). Perioperative, pathological, functional, and oncological outcomes were compared. Kaplan‐Meier survival curves and log‐rank tests were used to assess biochemical recurrence (BCR) and functional recovery.ResultsMedian follow‐up was 72 months. Patients in Group B were older (65 vs. 63 years, p < 0.001), had higher PSA (6.20 vs. 5.76 ng/mL, p < 0.001), and lower PSA density (0.09 vs. 0.12 ng/mL/cc, p < 0.001). Group B had more low‐risk disease (29.8% vs. 24.1%, p < 0.001) and ISUP Grade Group 1 on biopsy (36.1% vs. 26.7%, p < 0.001). Operative time was longer in Group B (119 vs. 110 min, p < 0.001). Continence outcomes were comparable (p = 0.3). Among patients aged < 55 years with baseline SHIM > 21, potency recovery was high regardless of EML or nerve‐sparing status. Group B demonstrated a significantly lower 10‐year cumulative BCR rate (p = 0.042).ConclusionsRARP in patients with EML is associated with favorable oncological outcomes and equivalent continence recovery. Potency recovery is primarily influenced by age and baseline sexual function, rather than EML presence or nerve‐sparing.Trial Registration: This study is part of the prostate cancer registry (No. 237998). 10.1002/pros.70021 http://onlinelibrary.wiley.com/termsAndConditions#vor
title Impact of Intraoperative Enlarged Median Lobe on Functional Recovery Following Robot‐Assisted Radical Prostatectomy: A Retrospective Cohort Analysis
topic The Prostate
url https://onlinelibrary.wiley.com/doi/10.1002/pros.70021